CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types.

被引:0
|
作者
Nong, L [1 ]
Newton, C [1 ]
Friedman, H [1 ]
Klein, TW [1 ]
机构
[1] Univ S Florida, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Marijuana cannabinoid receptors (CBR), CB1 and CB2, are G protein-coupled receptors reported to be expressed in brain as well as cells of the periphery. Human peripheral blood mononuclear cells (PBMCs) are reported to express CBR mRNA with CB2 expression higher than CB1 and expression in B cells higher than other cells. However, it is not known if the mRNA expression is constant among individuals of differing ages, gender, or ethnic origins. In the present study, PBMCs were obtained from a limited number of normal donors of both genders, of ages ranging from 21 to 55, and from Caucasian, and Asian ethnic origin. Using semi-quantitative RT-PCR, we confirmed previous reports that CB2 mRNA expression was higher than CB1 in PBMCs and in addition demonstrated that this basic profile was observed when stratified by age, gender, or ethnic origin. The latter results suggest that CBR expression is relatively constant across the human population.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 50 条
  • [1] PERIPHERAL BLOOD MONONUCLEAR CELLS CB1 AND CB2 RECEPTOR LEVELS IN FIRST EPISODES OF PSYCHOSIS
    Bioque, Miquel
    MacDowell, Karina
    Bueno, Borja
    Meseguer, Ana
    Cabrera, Bibiana
    Leza, Juan C.
    Bernardo, Miguel
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S135 - S136
  • [2] Enhanced mRNA levels of cannabinoid CB2 and CB1 receptors in peripheral blood mononuclear cells from marijuana smokers
    Kathmann, M
    Schlicker, E
    Faulhaber, J
    Leweke, FM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R76 - R76
  • [3] Expression of cannabinoid receptor 1 (CB1) and 2 (CB2) by human malignant cell lines and peripheral blood stem cells
    Srivastava, MD
    Srivastava, BI
    FASEB JOURNAL, 2001, 15 (04): : A25 - A25
  • [4] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [5] EXPRESSION OF CB1 AND CB2 IN HUMAN ATHEROSCLEROTIC PLAQUES
    Fazia, M. L.
    Di Francesco, A.
    De Cesare, D.
    Bucci, M.
    Ucchino, S.
    Spigonardo, F.
    Mezzetti, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 5 - 5
  • [6] Differential effects of CB1 and CB2 agonists on cAMP levels and MAP kinase activation in human peripheral blood mononuclear cells
    Makda, AA
    Elmore, MA
    Hill, ME
    Stamps, A
    Tejura, S
    Finnen, MJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S217 - S217
  • [7] Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
    Lopez De Jesus, Maider
    Hostalot, Cristina
    Garibi, Jesus M.
    Salles, Joan
    Javier Meana, J.
    Callado, Luis F.
    NEUROCHEMISTRY INTERNATIONAL, 2010, 56 (6-7) : 829 - 833
  • [8] Characterization of the expression of CB1 and CB2 in human atherosclerotic plaques
    Fazia, Maria Luigia
    Di Francesco, Andrea
    De Cesare, Domenico
    Bucci, Marco
    Spigonardo, Francesco
    Ucchino, Sante
    Mezzetti, Andrea
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A292 - A292
  • [9] Expression in Escherichia coli and characterisation of the human central CB1 and peripheral CB2 cannabinoid receptors
    Bernard Calandra
    Julie Tucker
    David Shire
    Reinhard Grisshammer
    Biotechnology Letters, 1997, 19 : 425 - 428
  • [10] Expression in Escherichia coli and characterisation of the human central CB1 and peripheral CB2 cannabinoid receptors
    Calandra, B
    Tucker, J
    Shire, D
    Grisshammer, R
    BIOTECHNOLOGY LETTERS, 1997, 19 (05) : 425 - 428